Literature DB >> 7214101

SL 75 102 as a gama-aminobutyric acid agonist: experiments on dorsal root ganglion neurones in vitro.

M Desarmenien, P Feltz, P M Headley, F Santangelo.   

Abstract

1 In anticipation that centrally active gamma-aminobutyric acid (GABA)-mimetic drugs may be clinically useful, derivatives of GABA with an imine link (Schiff base) to a lipophilic carrier have recently been prepared. The present paper concerns the actions of [alpha(4-chlorophenyl)5-fluoro, 2-hydroxy benzilidene-amino]-4-butanoate Na+, SL 75 102. 2 To test one aspect of the GABA-mimetic properties of SL 75 102, this compound was compared with GABA for activity on intracellularly-recorded neurones in rat dorsal root ganglia in vitro. On these neurones GABA, administered either by microiontophoresis or direct into the superfusion medium, causes a depolarization, due to an increased chloride conductance, followed by a period of desensitization. 3 The actions of Sl 75 102 were in nearly all respects identical to those of GABA; parameters examined were the effects on membrane potential and input conductance, desensitization, dose-response characteristics and sensitivity to the GABA antagonists, bicuculline and picrotoxin. 4 SL 75 102 was less potent than GABA (mean relative potency 0.03:1). 5 SL 75 102 therefore appears to be a weak agonist at GABA receptors of these neurones.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214101      PMCID: PMC2071499          DOI: 10.1111/j.1476-5381.1981.tb09135.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

Review 1.  Pharmacological characterization of different types of GABA and glutamate receptors in vertebrates and invertebrates.

Authors:  A Nistri; A Constanti
Journal:  Prog Neurobiol       Date:  1979       Impact factor: 11.685

2.  A model for an estimate in vivo of the ionic basis of presynaptic inhibition: an intracellular analysis of the GABA-induced depolarization in rat dorsal root ganglia.

Authors:  M Deschenes; P Feltz; Y Lamour
Journal:  Brain Res       Date:  1976-12-24       Impact factor: 3.252

Review 3.  Epilepsy and gamma-aminobutyric acid-mediated inhibition.

Authors:  B S Meldrum
Journal:  Int Rev Neurobiol       Date:  1975       Impact factor: 3.230

4.  The depolarizing responses to GABA in rat sensory ganglia in vivo and in vitro. A study of the role of glial uptake.

Authors:  M Desarmenien; P Feltz; P M Headley
Journal:  J Physiol (Paris)       Date:  1979

5.  Characteristics of muscimol accumulation in mouse brain after systemic administration.

Authors:  A Maggi; S J Enna
Journal:  Neuropharmacology       Date:  1979-04       Impact factor: 5.250

6.  Do glia influence neuronal responses to GABA in the rat? [proceedings].

Authors:  M Desarmenien; P Feltz; P M Headley
Journal:  J Physiol       Date:  1979-04       Impact factor: 5.182

7.  Distribution and metabolism of muscimol in the brain and other tissues of the rat.

Authors:  M Baraldi; L Grandison; A Guidotti
Journal:  Neuropharmacology       Date:  1979-01       Impact factor: 5.250

8.  (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor.

Authors:  N G Bowery; D R Hill; A L Hudson; A Doble; D N Middlemiss; J Shaw; M Turnbull
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

9.  Influence of neuroglial transport on the action of gamma-aminobutyric acid on mammalian ganglion cells.

Authors:  D A Brown; M Galvan
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

10.  Characterization and ionic basis of GABA-induced depolarizations recorded in vitro from cat primary afferent neurones.

Authors:  J P Gallagher; H Higashi; S Nishi
Journal:  J Physiol       Date:  1978-02       Impact factor: 5.182

View more
  7 in total

1.  Dynamic modelling of the binding of substances to the conserved membrane-adjacent heptapeptide of the 15-residue C-terminal cytoplasmic fragment of mammalian dopamine D2 receptors.

Authors:  E Roberts; J Wendel
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Submassive hepatic necrosis associated with the use of progabide: a GABA receptor agonist.

Authors:  S J Munoz; R Fariello; W C Maddrey
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

3.  An arylaminopyridazine derivative of gamma-aminobutyric acid (GABA) is a selective and competitive antagonist at the GABAA receptor site.

Authors:  J P Chambon; P Feltz; M Heaulme; S Restle; R Schlichter; K Biziere; C G Wermuth
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Comparative study of GABA-mediated depolarizations of lumbar A delta and C primary afferent neurones of the rat.

Authors:  M Desarmenien; F Santangelo; J P Loeffler; P Feltz
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

5.  Isothiouronium compounds as gamma-aminobutyric acid agonists.

Authors:  R D Allan; H W Dickenson; B P Hiern; G A Johnston; R Kazlauskas
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

6.  Coexistence of GABAA and GABAB receptors on A delta and C primary afferents.

Authors:  M Désarmenien; P Feltz; G Occhipinti; F Santangelo; R Schlichter
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

7.  Electrophysiological study of SR 42641, a novel aminopyridazine derivative of GABA: antagonist properties and receptor selectivity of GABAA versus GABAB responses.

Authors:  M Desarmenien; E Desaulles; P Feltz; M Hamann
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.